Mol. Cells 2011; 32(4): 389-395
Published online September 7, 2011
https://doi.org/10.1007/s10059-011-0157-9
© The Korean Society for Molecular and Cellular Biology
Mi Jin Moon, Hee Young Kim1, Sumi Park, Dong-Kyu Kim, Eun Bee Cho, Jong-Ik Hwang, and Jae Young Seong*
Correspondence to : *Correspondence: jyseong@korea.ac.kr
Glucagon-like peptide-1 (GLP-1) stimulates insulin secre-tion from pancreatic ?-cells in a glucose-dependent man-ner. However, factors other than glucose that regulate the β-cell response to GLP-1 remain poorly understood. In this study, we examined the possible involvement of insulin and receptor tyrosine kinase signaling in regulation of the GLP-1 responsiveness of beta-cells. Pretreatment of beta-cells with HNMPA, an insulin receptor inhibitor, and AG1478, an epidermal growth factor receptor inhibitor, further increased the cAMP level and Erk phosphorylation in the presence of exendin-4 (exe-4), a GLP-1 agonist. When beta-cells were exposed to a high concentration of glucose (25 mM), which stimulates insulin secretion, exe-4-induced cAMP formation declined gradually as exposure time was increased. This decreased cAMP formation was not observed in the presence of HNMPA. HNMPA was able to further increase the exe-4-induced insulin secretion when beta-cells were exposed to high glucose for 18 h. Treatment of beta-cells with insulin significantly decreased exe-4-induced cAMP formation in a dose-dependent manner. Lowering the phospho-Akt level by HNMPA or LY294002, a PI3K in-hibitor, further augmented exe-4-induced cAMP forma-tion and Erk phosphorylation. These results suggest that insulin contributes to fine-tuning of the beta-cell response to GLP-1.
Keywords beta-cells, cAMP, Erk, GLP-1, insulin, RTK
Mol. Cells 2011; 32(4): 389-395
Published online October 31, 2011 https://doi.org/10.1007/s10059-011-0157-9
Copyright © The Korean Society for Molecular and Cellular Biology.
Mi Jin Moon, Hee Young Kim1, Sumi Park, Dong-Kyu Kim, Eun Bee Cho, Jong-Ik Hwang, and Jae Young Seong*
Graduate School of Medicine, Korea University, Seoul 136-705, Korea, 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul 136-705, Korea
Correspondence to:*Correspondence: jyseong@korea.ac.kr
Glucagon-like peptide-1 (GLP-1) stimulates insulin secre-tion from pancreatic ?-cells in a glucose-dependent man-ner. However, factors other than glucose that regulate the β-cell response to GLP-1 remain poorly understood. In this study, we examined the possible involvement of insulin and receptor tyrosine kinase signaling in regulation of the GLP-1 responsiveness of beta-cells. Pretreatment of beta-cells with HNMPA, an insulin receptor inhibitor, and AG1478, an epidermal growth factor receptor inhibitor, further increased the cAMP level and Erk phosphorylation in the presence of exendin-4 (exe-4), a GLP-1 agonist. When beta-cells were exposed to a high concentration of glucose (25 mM), which stimulates insulin secretion, exe-4-induced cAMP formation declined gradually as exposure time was increased. This decreased cAMP formation was not observed in the presence of HNMPA. HNMPA was able to further increase the exe-4-induced insulin secretion when beta-cells were exposed to high glucose for 18 h. Treatment of beta-cells with insulin significantly decreased exe-4-induced cAMP formation in a dose-dependent manner. Lowering the phospho-Akt level by HNMPA or LY294002, a PI3K in-hibitor, further augmented exe-4-induced cAMP forma-tion and Erk phosphorylation. These results suggest that insulin contributes to fine-tuning of the beta-cell response to GLP-1.
Keywords: beta-cells, cAMP, Erk, GLP-1, insulin, RTK
Mi Jin Moon, Hee Young Kim, Sin Gon Kim, Juri Park, Dong Seop Choi, Jong-Ik Hwang, and
Jae Young Seong*
Yan Lin, Jia Liu, Jia Chen, Chun Yao, Yunwen Yang, Jie Wang, Hongqin Zhuang, and Zi-Chun Hua
Mol. Cells 2020; 43(4): 373-383 https://doi.org/10.14348/molcells.2020.2198Da Eun Jeong, Sungeun Heo, Ji Hye Han, Eun-young Lee, Rohit N. Kulkarni, and Wook Kim
Mol. Cells 2018; 41(10): 909-916 https://doi.org/10.14348/molcells.2018.0147